To begin the new year, the FDA released six draft guidances and an information sheet to aid the development and conduct of clinical trials, including three dealing with accounting for gender in trials. The other new guidance examines tissue biopsies, confirmatory trials for accelerated approval, and developing products for optical imaging and obesity. A draft guidance on the ... Read More